CClinicalTrials.gg
CompletedNCT02429336Updated Nov 13, 2020

Characteristics of Women With Reproductive Concerns

An observational study in Endocrine Disorders of Female Reproductive System, sponsored by University of Tennessee. Completed at 1 site in United States. Open to female participants aged 8 Years and older. Per ClinicalTrials.gov, last updated 2020-11-13.

Sponsored by University of Tennessee · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
194
Ages
8 Years and older
Sex
Female
01

Study summary

The purpose of this study is to collect data that will be generated during an office visit. The data will be gathered and analyzed in research studies that will help with the investigators understanding of various medical conditions.

About 200 subjects will be participating in this study. Participation in this study will not require a patient's time or presence. The medical information contained in a patient's chart from the office visit, including the results of any tests that were ordered at that time, will be transferred to an anonymous database and analyzed together with data from other patients who have similar condition/s.

No follow-up information will be collected. The following information will be collected from a patient's medical record: the medical history and a list of the current medications.

Read the detailed description

Purpose: To collect the characteristics of patients presenting to the reproductive endocrinology clinic.

Rationale: Patients' characteristics will be analyzed as part of clinical research studies and may help in understanding the causes of their condition.

02

Conditions studied

  • Endocrine Disorders of Female Reproductive System
03

In context

Endocrine System Diseases

307 studies on the registry are indexed under Endocrine System Diseases; 52 are open to participants now.

This study's enrollment of 194 is close to the median of 200 across 84 observational studies indexed under Endocrine System Diseases.

Browse Endocrine System Diseases studies →

Lead sponsor

University of Tennessee is the lead sponsor of 139 studies on the registry; 21 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 2 (29%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Population: All patients presenting to the reproductive endocrinology clinic.

Inclusion criteria

  • females of childbearing potential experiencing reproductive endocrinology related problems

Exclusion criteria

Exclusion Criteria:

  • male or female not of childbearing potential
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
194 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Data collection from patients' charts.

    Data collection from patients' charts.

    Time frame: up to 1 year from the time of signing the informed consent for data collection

07

Study locations

1 site
  • Regional One Health Ob-Gyn Clinic
    Memphis, Tennessee 38103, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 13, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02429336
Lead sponsor
University of Tennessee
Responsible party
Sponsor
First posted
Apr 29, 2015
Start date
Jan 2012
Primary completion
Jun 30, 2020
Completion
Jun 30, 2020
Last update
Nov 13, 2020

Study contacts

Laura Detti, M.D.
principal investigator · Associate Professor, UTennessee Health Science Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion